Larvol Delta - The-Current-Status-of-Radionuclide-Tumor-Targeting-Diagnosis-and-Therapy-Based-on-FAP2286-From-Preclinical-Studies-to-Clinical-Application

lutetium Lu 177 rofapitide tetraxetan (AAA614) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/41582290

Chunyin Zhang; Huajun Liu; Junzheng Wang; Zhen Yang

Jan 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next